Will the new hypoglycaemic agents be effective on renal and cardiovascular protection in diabetes and renal diabetic disease? Alberto Martinez-Castelao, M. José Soler, Juan F. Navarro-González, José Luis Górriz

Is long-term immunosuppression without anti-calcineurinic agents safe in renal transplantation? J. M. Díaz

What are the benefits and risks of calcimimetic agents in the management of secondary hyperparathyroidism in chronic renal failure? F. Rivera